Hope As I ate breakfast one morning, I overheard two oncologists conversing. One complained bitterly, "You know, Bob, I just don't understand it. We used the same drugs, the same dosage, the same schedule and the same entry criteria. Yet I got a 22 percent response rate and you got a 74 percent. That's unheard of for metastatic cancer. How do you do it?" His colleague replied, "We're both using Etoposide, Platinum, Oncovin and Hydroxyurea. You call yours EPOH. I tell my patients I'm giving them HOPE. As dismal as the statistics are, I emphasize that we have a chance.